United States

CND thematic sessions on the implementation of all international drug policy commitments, following-up to the 2019 Ministerial Declaration – 21 September 2022

Multiyear Workplan 2019-2023: Implementation of all our international drug policy commitments, following up to the 2019 ministerial declaration “Strengthening Our Actions at the National, Regional and International Levels to Accelerate the Implementation of our Joint Commitments to Address and Counter the World Drug Problem”  The provisional agenda for the intersessional meeting is as follows: 1. Thematic …

Read more

Committee of the Whole L5. Promoting comprehensive and scientific evidence-based early prevention

Slovenia: we had constructive informals that redefined the word ‘flexibility’ but we thank all delegates for their constructive approach. We confirmed to delete PP11bis, amend PP11ter and this is agreed in informals. Chair: What is the feeling of the room regarding PP11bis and PP11ter? Are there any comments? I see none. Let’s consider both agreed …

Read more

Committee of the Whole L7. Intensifying efforts to address the proliferation of uncontrolled and designer precursors used in the illicit manufacture of drugs

Secretariat: There will be an informal on L5 in a hybrid format on BR-A. L7 – Technical amendment. On OP12 & 13 – There is in square brackets ‘or trafficking’. There was an omission to delete this part. Just checking with the CoW. Ok, we can continue. United States: We engaged in consultations, not in …

Read more

Plenary Item 7. Inter-agency cooperation and coordination of efforts in addressing and countering the world drug problem

CHAIR: Introduction to Item 7 UNODC: We have produced a communication package to UN countries to help them see how the UN system can better support implementation of drug policy. This package includes relevant guidelines and considerations. We hope to report even more progress next year. UNODC: (…) drug prevention, treatment and care based on scientific …

Read more